Navigation Links
CORRECTED - Akorn, Inc. Announces Date Change for Third Quarter 2010 Earnings Release and Conference Call
Date:10/13/2010

LAKE FOREST, Ill., Oct. 13 /PRNewswire-FirstCall/ -- Akorn, Inc. (Nasdaq: AKRX) will host a conference call on Tuesday, November 2, 2010, to discuss third quarter 2010 results followed by a Q&A session.  The company will release earnings the same day before the market opens. Subject:

Akorn Third Quarter 2010 Conference CallDate/Time:

Tuesday, November 2, 2010, at 10:00 a.m. Eastern TimeDomestic Callers:

(888) 215-6895International Callers:

(913) 312-0860Confirmation Code:

2146785URL For Webcast:

http://www.videonewswire.com/event.asp?id=73076A live broadcast of Akorn's conference call will also be available online at www.akorn.com under the investor relations tab on November 2, 2010, beginning at 10:00 a.m. (Eastern Time).  The online replay will follow immediately and will be available for 30 days.  Please note, later in the afternoon on November 2nd Raj Rai and Tim Dick will be presenting at the Oppenheimer 21st Annual Healthcare Conference in New York at the Waldorf Astoria.

About Akorn, Inc.Akorn, Inc. is a niche pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals.  Akorn has manufacturing facilities located in Decatur, Illinois and Somerset, New Jersey where the Company manufactures ophthalmic and injectable pharmaceuticals.  Additional information is available on the Company's website at www.akorn.com.


'/>"/>

SOURCE Akorn, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Akorn, Inc. Announces Third Quarter 2010 Earnings Release and Conference Call Information
2. Prime Therapeutics Announces URAC Accreditation
3. Regeneron Announces Exercise of Over-Allotment Option and Closing of Underwritten Offering of Common Stock
4. Cellectis bioresearch Announces Establishment of Subsidiary in the US
5. BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX® for Treatment of Peyronies Disease
6. Titan Pharmaceuticals Announces Journal of the American Medical Association Publication of Phase 3 Probuphine™ Data
7. Misonix Announces Change in Distribution of SonaStar® Surgical Aspiration System in the U.S.
8. Express Scripts Announces Third Quarter 2010 Earnings and 2011 Earnings Guidance Conference Call
9. Archimedes Pharma Announces Publication of Long-Term Safety and Tolerability Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in the Journal of Opioid Management
10. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
11. Adeona Announces Five Scientific Publications on Role of Copper Toxicity and Zinc Deficiency in Alzheimers Disease and Cognitive Decline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... India , December 5, 2016 According ... by Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free ... published by MarketsandMarkets, the market is projected to reach USD 779.8 ... a CAGR of 13.5% during the forecast period of 2016 to ... ...
(Date:12/5/2016)... Sanovas, Inc., a life science asset holding company ... wholly owned subsidiary, Intubation Science, Inc., and its LightSpeed Intubation ... http://photos.prnewswire.com/prnh/20161202/445251LOGO   ... Sanovas, Inc. ... There are over 40 million Endotracheal Intubations performed annually ...
(Date:12/5/2016)... WOONSOCKET, R.I. , Dec. 5, 2016 /PRNewswire/ ... CVS ) Research Institute and the U.S. ... the Assistant Secretary for Preparedness and Response (ASPR), ... showed that automated pharmacy notifications encourage patients ... a forecasted natural disaster. The study also affirms ...
Breaking Medicine Technology:
(Date:12/5/2016)... Diego, CA (PRWEB) , ... December 05, 2016 , ... ... seen and heard the dangers and downsides of patients who do not do their ... The field of cosmetic dermatology is in the midst of a renaissance and every ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Rejuvenation" at the 2016 Anti-Aging & Beauty Awards at The Aesthetic & ... & Anti-aging Medicine European Congress (AMEC) brings together the industry’s leading scientific ...
(Date:12/5/2016)... ... December 05, 2016 , ... A ... Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with little ... , Over the last 60 years, studies have shown that single electrode misplacement ...
(Date:12/4/2016)... ... 03, 2016 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... New York City, with long-time partners The Paul Foundation, on November 10, 2016. ...
(Date:12/4/2016)... , ... December 03, 2016 , ... While James Earl ... serving as host for in a show called "Front Page". One of the forthcoming ... years, breast cancer rates have plummeted in large part due to early detection. Like ...
Breaking Medicine News(10 mins):